Search

Your search keyword '"Cannalire, R."' showing total 45 results

Search Constraints

Start Over You searched for: Author "Cannalire, R." Remove constraint Author: "Cannalire, R."
45 results on '"Cannalire, R."'

Search Results

1. An overview on small molecules acting as broad-spectrum agents for yellow fever infection

5. Isocyanide chemistry enabled by continuous flow technology

6. Visible light photocatalysis in the late-stage functionalization of pharmaceutically relevant compounds

7. Visible-Light Photocatalytic Ugi/Aza-Wittig Cascade towards 2-Aminomethyl-1,3,4-oxadiazole Derivatives

8. Visible-Light Photocatalytic Functionalization of Isocyanides for the Synthesis of Secondary Amides and Ketene Aminals

9. Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants

10. Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position

11. Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives

13. Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses.

14. Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination.

15. Domino synthesis of 5-aminoimidazoles from Strecker multicomponent adducts via ytterbium-promoted isocyanide insertion/5-exo-dig cyclization.

16. Easy access to α-ketoamides as SARS-CoV-2 and MERS M pro inhibitors via the PADAM oxidation route.

17. An overview on small molecules acting as broad-spectrum agents for yellow fever infection.

18. Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities.

19. Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities.

20. Photomicellar Catalyzed Synthesis of Amides from Isocyanides: Optimization, Scope, and NMR Studies of Photocatalyst/Surfactant Interactions.

21. From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search.

22. Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi.

23. Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen.

24. Visible light photocatalysis in the late-stage functionalization of pharmaceutically relevant compounds.

25. Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View.

26. C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors.

27. Visible-Light Photocatalytic Functionalization of Isocyanides for the Synthesis of Secondary Amides and Ketene Aminals.

28. Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors.

29. SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells.

30. Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase.

31. Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation.

32. Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions.

33. Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants.

34. 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.

35. Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position.

36. Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase.

37. Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.

38. Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues.

39. Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli .

40. Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor.

41. A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates.

42. Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium.

43. The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors.

44. New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors.

45. The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors.

Catalog

Books, media, physical & digital resources